Neuren Pharmaceuticals Ltd (NURPF)
12.51
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Neuren Pharmaceuticals Price: 12.51 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 0.000 |
May 02, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 0.000 |
May 01, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 0.000 |
Apr 30, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 500.00 |
Apr 29, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 0.000 |
Apr 26, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 0.000 |
Apr 25, 2024 | 12.51 | 12.51 | 12.51 | 12.51 | 600.00 |
Apr 24, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 23, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 22, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 19, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 18, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 17, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 16, 2024 | 12.53 | 12.53 | 12.53 | 12.53 | 0.000 |
Apr 15, 2024 | 12.66 | 12.66 | 12.53 | 12.53 | 1000.00 |
Apr 12, 2024 | 13.36 | 13.36 | 13.36 | 13.36 | 0.000 |
Apr 11, 2024 | 13.36 | 13.36 | 13.36 | 13.36 | 500.00 |
Apr 10, 2024 | 13.70 | 13.70 | 13.70 | 13.70 | 0.000 |
Apr 09, 2024 | 13.70 | 13.70 | 13.70 | 13.70 | 0.000 |
Apr 08, 2024 | 13.70 | 13.70 | 13.70 | 13.70 | 100.00 |
Apr 05, 2024 | 13.74 | 13.74 | 13.74 | 13.74 | 0.000 |
Apr 04, 2024 | 13.74 | 13.74 | 13.74 | 13.74 | 600.00 |
Apr 03, 2024 | 13.45 | 13.45 | 13.45 | 13.45 | 0.000 |
Apr 02, 2024 | 13.45 | 13.45 | 13.45 | 13.45 | 0.000 |
Apr 01, 2024 | 13.45 | 13.45 | 13.45 | 13.45 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.55
Minimum
Mar 24 2020
17.16
Maximum
Dec 28 2023
4.016
Average
1.91
Median
Jan 24 2020
Price Benchmarks
Alterity Therapeutics Ltd | 2.05 |
Kazia Therapeutics Ltd | 0.272 |
Immutep Ltd | 2.82 |
Opthea Ltd | 3.418 |
Mesoblast Ltd | 7.50 |
Price Related Metrics
PE Ratio | 15.87 |
PS Ratio | 10.76 |
Price to Book Value | 11.61 |
Earnings Yield | 6.30% |
Market Cap | 1.623B |
Operating PE Ratio | 12.54 |
Normalized PE Ratio | 15.87 |